No Data
Qingdao Vland Biotech INC. (SHSE:603739) Stocks Shoot Up 28% But Its P/E Still Looks Reasonable
Qingdao Vland Biotech's (SHSE:603739) Anemic Earnings Might Be Worse Than You Think
Blue Biotech: Report for the third quarter of 2024 from Qingdao Weilan Biology Co., Ltd.
Qingdao Weilan Biology Co., Ltd. Report for the Third Quarter of 2024
Announcement of the main operating data of Qingdao Weilan Biology Co., Ltd. for the third quarter of 2024
qingdao vland biotech inc. (603739.SH): The net income for the first three quarters was approximately 40.85 million yuan, a decrease of 26.17% year-on-year.
On October 28, Gelonhui reported that qingdao vland biotech inc. (603739.SH) announced that the revenue for the first three quarters of 2024 was approximately 0.946 billion yuan, an increase of 7.5% year-on-year; the net income attributable to the shareholders of the listed company was approximately 40.85 million yuan, a decrease of 26.17% year-on-year; and the basic earnings per share was 0.16 yuan.
